Robinson S, Cohen A R
Division of Pediatric Neurological Surgery, Rainbow Babies and Childrens Hospital, and Department of Neurological Surgery, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA.
Neurosurgery. 2000 Feb;46(2):371-83. doi: 10.1097/00006123-200002000-00021.
Lhermitte-Duclos disease, or dysplastic gangliocytoma of the cerebellum, is an unusual hamartomatous lesion that can cause progressive mass effects in the posterior fossa. Cowden disease, or multiple hamartoma-neoplasia syndrome, is a rare autosomal dominant disorder characterized by mucocutaneous hamartomas and high incidences of systemic malignancies. We recently treated a patient with manifestations of both Lhermitte-Duclos disease and Cowden disease, and we were intrigued by the occurrence of these two rare disorders in the same patient. The purpose of the present study was to examine the nature of the association between Lhermitte-Duclos disease and Cowden disease.
The records for all patients who had been diagnosed at our institution as having Lhermitte-Duclos disease were reviewed, to determine whether these patients also exhibited manifestations of Cowden disease. Data were obtained from multiple sources, including patient interviews, correspondence with treating physicians, and chart reviews.
During the past 40 years, five patients were diagnosed at Case Western Reserve University as having Lhermitte-Duclos disease. All five patients exhibited manifestations of Cowden disease. Before this review, Cowden disease had not been diagnosed for three of the patients. In our most recent case, the diagnoses of both disorders were established preoperatively. That patient was observed to have a deletion in the critical portion of Exon 5 of the PTEN gene, the gene associated with Cowden disease.
Inclusion of Lhermitte-Duclos disease in the Cowden disease spectrum suggests that Cowden disease is a true phakomatosis, with hamartomas arising from cutaneous and neural ectoderm. Recent advances in molecular genetics may help to refine the current descriptive classification of the phakomatoses. The association between Lhermitte-Duclos disease and Cowden disease has been under-recognized and under-reported. Recognition of this association has direct clinical relevance, because diligent long-term follow-up monitoring of individuals with Lhermitte-Duclos disease and Cowden disease may lead to the early detection of malignancy.
Lhermitte-Duclos病,即小脑发育异常性神经节细胞瘤,是一种罕见的错构瘤性病变,可在后颅窝引起进行性占位效应。考登病,即多发性错构瘤-肿瘤综合征,是一种罕见的常染色体显性疾病,其特征为皮肤黏膜错构瘤和全身恶性肿瘤的高发病率。我们最近治疗了一名同时表现出Lhermitte-Duclos病和考登病症状的患者,这两种罕见疾病出现在同一患者身上让我们很感兴趣。本研究的目的是探讨Lhermitte-Duclos病与考登病之间关联的本质。
回顾了在我们机构被诊断为患有Lhermitte-Duclos病的所有患者的记录,以确定这些患者是否也表现出考登病的症状。数据来自多个来源,包括患者访谈、与主治医生的通信以及病历审查。
在过去40年中,凯斯西储大学诊断出5例患有Lhermitte-Duclos病的患者。所有5例患者均表现出考登病的症状。在本次审查之前,其中3例患者未被诊断出患有考登病。在我们最近的病例中,两种疾病的诊断均在术前确定。该患者被观察到PTEN基因第5外显子的关键部分存在缺失,PTEN基因与考登病相关。
将Lhermitte-Duclos病纳入考登病范畴表明,考登病是一种真正的斑痣性错构瘤病,错构瘤起源于皮肤和神经外胚层。分子遗传学的最新进展可能有助于完善目前斑痣性错构瘤病的描述性分类。Lhermitte-Duclos病与考登病之间的关联一直未得到充分认识和报道。认识到这种关联具有直接的临床意义,因为对患有Lhermitte-Duclos病和考登病的个体进行勤勉的长期随访监测可能有助于早期发现恶性肿瘤。